Research Article
Spexin Levels Are Associated with Metabolic Syndrome Components
Table 2
Spexin levels according to various definitions of MetS.
| | Median (–) | value | value |
| MetS criteria (overall) | NCEP ATP III | | | | Non-MetS | 0.26 (0.17–0.50) | <0.001 | 0.33 | MetS | 0.18 (0.13–0.24) | World Health Organization (WHO) | | | | Non-MetS | 0.27 (0.17–0.50) | <0.001 | 0.05 | MetS | 0.18 (0.13–0.23) | International Diabetes Federation (IDF) | | | | Non-MetS | 0.21 (0.16–0.50) | 0.009 | 0.95 | MetS | 0.17 (0.13–0.31) | Female | NCEP ATP III | | | | Non-MetS | 0.28 (0.18–0.58) | 0.001 | 0.62 | MetS | 0.19 (0.15–0.33) | World Health Organization (WHO) | | | | Non-MetS | 0.31 (0.18–0.55) | <0.001 | 0.18 | MetS | 0.19 (0.13–0.31) | International Diabetes Federation (IDF) | | | | Non-MetS | 0.28 (0.18–0.58) | 0.03 | 0.89 | MetS | 0.19 (0.15–0.37) | Male | NCEP ATP III | | | | Non-MetS | 0.18 (0.14–0.20) | 0.56 | 0.34 | MetS | 0.16 (0.13–0.19) | World Health Organization (WHO) | | | | Non-MetS | 0.17 (0.12–0.20) | 0.87 | 0.42 | MetS | 0.16 (0.13–0.19) | International Diabetes Federation (IDF) | | | | Non-MetS | 0.16 (0.12–0.19) | 0.96 | 0.80 | MetS | 0.16 (0.13–0.19) |
|
|
Note: Data presented as medians (1st quartile–3rd quartile). indicates values adjusted for age and BMI. |